Startups
2020
GATE2BRAIN SLImprove drug delivery across biological barriers through the use of a radically innovative peptide-based patented technology.
We focus on pediatric diseases such as Diffuse Intrinsic Pontine Glioma (DIPG).
We focus on pediatric diseases such as Diffuse Intrinsic Pontine Glioma (DIPG).
Address
Carrer de Baldiri Reixac 4-8, 08028 Barcelona, Spain
Finance Data
CERCA ownership
Barcelona, Spain
2005
Institut de Recerca Biomèdica (IRB Barcelona)
Barcelona, Spain
2015
Institut de Recerca Sant Joan de Déu (IRSJD)
CERCA Center Contact
CH
Cristina Horcajada
Institut de Recerca Biomèdica (IRB Barcelona)Other Catalan Public owners
Logo
Status & Deeptech areas
Company Status & Company Deeptech AreasCurrent company status
DeepTech Area
Spinoff information
Product description
Our lead asset (G2B-001) is a first-in-class therapeutic approach for solid tumors presenting harsh barriers to anticancer drug delivery.